Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00560) | |||||
---|---|---|---|---|---|
Name |
Progesterone
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
progesterone; 57-83-0; Pregn-4-ene-3,20-dione; Agolutin; Luteohormone; Crinone; 4-Pregnene-3,20-dione; Corpus luteum hormone; Syngesterone; Utrogestan; Luteol; Glanducorpin; Pregnenedione; Progesterol; Syngestrets; Corlutin; Cyclogest; Gesterol; Gestone; Gestormone; Progestin; Progestone; Progestron; Prometrium; Hormoflaveine; Methylpregnone; Progestasert; Progesteronum; Progestronol; Corlutina; Corluvite; Corporin; Flavolutan; Fologenon; Gynlutin; Gynolutone; Hormoluton; Lingusorbs; Lucorteum; Luteodyn; Luteogan; Luteopur; Luteosan; Luteostab; Luteovis; Lutociclina; Lutocyclin; Lutocylin; Lutoform; Lutromone; Membrettes; Nalutron; Piaponon; Primolut; Progekan; Progestosol; Prolidon; Proluton; Protormone; Syntolutan; Gestron; Lutidon; Lutogyl; Lutren; Prolets; Luteal hormone; Lucorteum Sol; Bio-luton; Lutocyclin M; Lipo-Lutin; Luteocrin normale; Luteinique; Prochieve; Prolutone; 17alpha-Progesterone; Synovex S; Projestaject; Gynoluton; Gesterol 50; Percutacrine Luteinique; Gesterol 100; Cyclogesterin; Akrolutin; Prolutin; Pregnene-3,20-dione; (S)-Progesterone; Colprosterone; Endometrin; Progesteron; Progestogel; Progeston; 3,20-Pregnene-4; Gelbkoerperhormon; Crinone progesterone gel; Gestiron; Lugesteron; Progestol; Luteol (VAN); Lutocuclin M; .beta.-Progesterone; Percutacrine; (S)-4-Pregnene-3,20-dione; Progeffik; Utrogest; Vitarrine; Luteum; Progesteronum [INN-Latin]; Delta(4)-pregnene-3,20-dione; Progesterona [INN-Spanish]; (S)-Pregn-4-en-3,20-dione; NSC-9704; delta(sup 4)-Pregnene-3,20-dione; CCRIS 533; Prontogest; Estima; 17.alpha.-Progesterone; HSDB 3389; Progesterone [Progestins]; AI3-51682; Prometrium (TN); Pregn-4-en-3,20-dione; UNII-4G7DS2Q64Y; Crinone (TN); 6alpha-Methylpregn-4-en-17alpha-ol-3,20-dione; CHEBI:17026; .delta.4-Pregnene-3,20-dione; 17alpha-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione; Pregn-4-ene-3,20-dione, 17alpha-hydroxy-6alpha-methyl-; component of Cyclogesterin; 4-Pregnen-3,20-dione; .delta.(sup4)-Pregnene-3,20-dione; CHEMBL103; D4-Pregnene-3,20-dione; MLS000028517; 4G7DS2Q64Y; NSC9704; NSC64377; MFCD00003658; NSC-64377; Progesterone, 98%; NCGC00015785-04; SMR000058345; DSSTox_CID_2370; U 3672; DSSTox_RID_76562; DSSTox_GSID_22370; 6.alpha.-Methylpregn-4-en-17.alpha.-ol-3,20-dione; 17.alpha.-Hydroxy-6.alpha.-methylpregn-4-ene-3,20-dione; Progesterona; Progestan; Pregn-4-ene-3,20-dione, 17.alpha.-hydroxy-6.alpha.-methyl-; 753497-20-0; SMR000653542; Progesterone (Prometrium); WLN: L E5 B666 OV MUTJ A1 E1 FV1; SR-01000000088; SR-01000076054; NSC 9704; EINECS 200-350-6; NSC 64377; Pregn-4-ene-3, 17.alpha.-hydroxy-6.alpha.-methyl-; BHR-100; Duraprogen; Progestrel; Lipolutin; Lutinus; Lutogynon; delta4-Pregnene-3,20-dione; Progesterone??; beta-Progesterone; progesterone group; 17a-Progesterone; CAS-57-83-0; delta(Sup4)-pregnene-3,20-dione; Progesterone [USP:INN:BAN:JAN]; racemic progesterone; Prestwick_411; Progesterone solution; Opera_ID_292; Progesterone, >=99%; Prestwick0_000477; Prestwick1_000477; Prestwick2_000477; Prestwick3_000477; Spectrum5_002053; Cyclogesterin (Salt/Mix); bmse000482; Epitope ID:116051; EC 200-350-6; Pregn-4-ne-3,20-ione; SCHEMBL7671; BIDD:PXR0094; Lopac0_000895; BSPBio_000614; MLS000758277; MLS001074187; MLS001423982; MLS002222367; BIDD:ER0547; P0130_SIGMA; SPBio_002553; .delta.-Pregnene-3,20-dione; BDBM8903; BPBio1_000676; GTPL2377; Hydroxyprogesterone Caproic acid; DTXSID3022370; Progesterone (JP17/USP/INN); BHR-310; ETI-411; HMS1569O16; HMS2051O05; HMS2090J07; HMS2096O16; HMS2230F23; HMS2233P11; HMS3262D12; HMS3713O16; Pregnene, 3,20-dione-delta^4-; BCP22000; HY-N0437; ZINC4428529; Tox21_113157; Tox21_201792; Tox21_300307; Tox21_500895; AC-700; CMC_13406; LMST02030159; SBB012538; AKOS015894908; Progesterone; 4-Pregnene-3,20-dione; ACN-032010; CCG-100766; CS-1937; DB00396; DR-2011; EBD2157912; LP00895; NC00016; SDCCGSBI-0050870.P002; Progesterone 1.0 mg/ml in Acetonitrile; NCGC00022185-03; NCGC00022185-04; NCGC00022185-05; NCGC00022185-06; NCGC00022185-07; NCGC00022185-08; NCGC00022185-09; NCGC00022185-10; NCGC00022185-11; NCGC00022185-12; NCGC00022185-14; NCGC00022185-21; NCGC00090798-01; NCGC00090798-02; NCGC00254120-01; NCGC00259341-01; NCGC00261580-01; AS-12660; CPD000058345; NCI60_042166; ST069329; FE-999913; EU-0100895; (14beta,17alpha)-pregn-4-ene-3,20-dione; Progesterone, meets USP testing specifications; Progesterone, Vetec(TM) reagent grade, 98%; 6370-EP1441224A2; 6370-EP2269989A1; 6370-EP2269990A1; 6370-EP2275420A1; 6370-EP2284149A1; 6370-EP2289892A1; 6370-EP2292088A1; 6370-EP2292233A2; 6370-EP2292592A1; 6370-EP2295055A2; 6370-EP2295416A2; 6370-EP2298731A1; 6370-EP2298748A2; 6370-EP2298764A1; 6370-EP2298765A1; 6370-EP2298772A1; 6370-EP2305636A1; 6370-EP2305642A2; 6370-EP2308839A1; 6370-EP2308880A1; 6370-EP2311453A1; C00410; D00066; J10165; P 0130; Q26963; S00293; 10324-EP2295503A1; 10324-EP2301536A1; 10324-EP2301538A1; 10324-EP2311455A1; 10324-EP2316452A1; Progesterone, VETRANAL(TM), analytical standard; Q-201624; SR-01000000088-5; SR-01000000088-6; SR-01000076054-1; SR-01000076054-4; BRD-K64994968-001-03-6; 32104FB6-BF81-4F6E-83C2-024DEEAEB272; Progesterone, British Pharmacopoeia (BP) Reference Standard; Progesterone, powder, BioReagent, suitable for cell culture; Progesterone, European Pharmacopoeia (EP) Reference Standard; Progesterone, gamma-irradiated, BioXtra, suitable for cell culture; Progesterone, United States Pharmacopeia (USP) Reference Standard; Progesterone-Water Soluble, powder, BioReagent, suitable for cell culture; Progesterone, Pharmaceutical Secondary Standard; Certified Reference Material; 137940-28-4
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Endometrial hyperplasia | ICD-11: GA16 | [1] | ||
PubChem CID | |||||
Formula |
C21H30O2
|
||||
Canonical SMILES |
CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C
|
||||
InChI |
1S/C21H30O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h12,16-19H,4-11H2,1-3H3/t16-,17+,18-,19-,20-,21+/m0/s1
|
||||
InChIKey |
RJKFOVLPORLFTN-LEKSSAKUSA-N
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=5994"></iframe>
|
||||
3D MOL | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 314.5 | Topological Polar Surface Area | 34.1 | |
XlogP | 3.9 | Complexity | 589 | ||
Heavy Atom Count | 23 | Rotatable Bond Count | 1 | ||
Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 2 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Progesterone 100 mg capsule | Click to Show/Hide the Full List of Formulation(s): 8 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c red no. 40; Ammonia; Ferrosoferric oxide; Glycerin; Propylene glycol; Titanium dioxide; Lecithin, soybean; Gelatin; Peanut oil; Shellac
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Dr Reddy's Laboratories | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Soybean lecithin | DIG Info | Albendazole monooxygenase (IC50 = 6.61 mg.mL-1) | [4] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c red no. 40; Ammonia; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Lecithin, soybean; Gelatin, unspecified; Peanut oil; Shellac
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Golden State Medical Supply | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Soybean lecithin | DIG Info | Albendazole monooxygenase (IC50 = 6.61 mg.mL-1) | [4] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c yellow no. 6; Glycerin; Titanium dioxide; Water; Lecithin, soybean; Gelatin; Peanut oil
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Amneal Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Soybean lecithin | DIG Info | Albendazole monooxygenase (IC50 = 6.61 mg.mL-1) | [4] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c red no. 40; Glycerin; Titanium dioxide; Lecithin, soybean; Gelatin; Peanut oil
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Bryant Ranch Prepack; PD-Rx Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Soybean lecithin | DIG Info | Albendazole monooxygenase (IC50 = 6.61 mg.mL-1) | [4] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c red no. 40; Glycerin; Titanium dioxide; Gelatin; Peanut oil
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Physicians Total Care | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Ferric oxide red; Ferrosoferric oxide; Glycerin; Propylene glycol; Titanium dioxide; Lecithin, soybean; Polyethylene glycol 400; Gelatin, unspecified; Peanut oil; Polyvinyl acetate phthalate
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Teva Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Soybean lecithin | DIG Info | Albendazole monooxygenase (IC50 = 6.61 mg.mL-1) | [4] | |||
Polyethylene glycol 400 | DIG Info | Albendazole monooxygenase (IC50 = 10.77 mg.mL-1) | [4] | |||
Drug Formulation 7 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Ferric oxide red; Ferric oxide yellow; Glycerin; Titanium dioxide; Lecithin, soybean; Gelatin; Peanut oil
|
|||||
Dosage Form | Oral Capsule | |||||
Company | A-S Medication Solutions; AvKARE; Banner Life Sciences; Banner Pharmacaps; Bionpharma; Golden State Medical Supply; NuCare Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Soybean lecithin | DIG Info | Albendazole monooxygenase (IC50 = 6.61 mg.mL-1) | [4] | |||
Drug Formulation 8 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Ferric oxide red; Ferric oxide yellow; Glycerin; Titanium dioxide; Lecithin, soybean; Gelatin, unspecified; Peanut oil
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Bryant Ranch Prepack | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Soybean lecithin | DIG Info | Albendazole monooxygenase (IC50 = 6.61 mg.mL-1) | [4] | |||
Progesterone 200 mg capsule | Click to Show/Hide the Full List of Formulation(s): 9 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Ammonia; Ferrosoferric oxide; Glycerin; Propylene glycol; Titanium dioxide; Lecithin, soybean; Gelatin, unspecified; Peanut oil; Shellac
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Golden State Medical Supply | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Soybean lecithin | DIG Info | Albendazole monooxygenase (IC50 = 6.61 mg.mL-1) | [4] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Ammonia; Ferrosoferric oxide; Glycerin; Propylene glycol; Titanium dioxide; Lecithin, soybean; Gelatin; Peanut oil; Shellac
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Dr Reddy's Laboratories | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Soybean lecithin | DIG Info | Albendazole monooxygenase (IC50 = 6.61 mg.mL-1) | [4] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c yellow no. 6; Glycerin; Titanium dioxide; Water; Lecithin, soybean; Gelatin; Peanut oil
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Amneal Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Soybean lecithin | DIG Info | Albendazole monooxygenase (IC50 = 6.61 mg.mL-1) | [4] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c yellow no. 6; Glycerin; Titanium dioxide; Lecithin, soybean; Gelatin, unspecified; Peanut oil
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Bryant Ranch Prepack | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Soybean lecithin | DIG Info | Albendazole monooxygenase (IC50 = 6.61 mg.mL-1) | [4] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c yellow no. 6; Glycerin; Titanium dioxide; Lecithin, soybean; Gelatin; Peanut oil
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Bryant Ranch Prepack; PD-Rx Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Soybean lecithin | DIG Info | Albendazole monooxygenase (IC50 = 6.61 mg.mL-1) | [4] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c yellow no. 6; Glycerin; Titanium dioxide; Gelatin; Peanut oil
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Physicians Total Care | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Drug Formulation 7 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Ferric oxide yellow; Ferrosoferric oxide; Glycerin; Propylene glycol; Titanium dioxide; Lecithin, soybean; Polyethylene glycol 400; Gelatin, unspecified; Peanut oil; Polyvinyl acetate phthalate
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Teva Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Soybean lecithin | DIG Info | Albendazole monooxygenase (IC50 = 6.61 mg.mL-1) | [4] | |||
Polyethylene glycol 400 | DIG Info | Albendazole monooxygenase (IC50 = 10.77 mg.mL-1) | [4] | |||
Drug Formulation 8 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Ferric oxide red; Glycerin; Titanium dioxide; Lecithin, soybean; Gelatin; Peanut oil
|
|||||
Dosage Form | Oral Capsule | |||||
Company | AvKARE; Banner Life Sciences; Banner Pharmacaps; Bionpharma; Golden State Medical Supply | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Soybean lecithin | DIG Info | Albendazole monooxygenase (IC50 = 6.61 mg.mL-1) | [4] | |||
Drug Formulation 9 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Glycerin; Titanium dioxide; Lecithin, soybean; Gelatin; Peanut oil
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Akorn; AvKARE | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Soybean lecithin | DIG Info | Albendazole monooxygenase (IC50 = 6.61 mg.mL-1) | [4] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.